scholarly article | Q13442814 |
P356 | DOI | 10.1097/MNH.0B013E3283562390 |
P953 | full work available online at | https://journals.lww.com/10.1097/MNH.0b013e3283562390 |
P698 | PubMed publication ID | 22801443 |
P50 | author | Kenneth Hallows | Q60057868 |
P2093 | author name string | Núria M. Pastor-Soler | |
P2860 | cites work | Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade | Q21245891 |
Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia | Q24290495 | ||
Structure of mammalian AMPK and its regulation by ADP | Q24296973 | ||
Mammalian AMP-activated protein kinase subfamily | Q24316251 | ||
AMP-activated protein kinase downregulates Kv7.1 cell surface expression | Q24338892 | ||
Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase | Q24617464 | ||
AMP-activated protein kinase inhibits alkaline pH- and PKA-induced apical vacuolar H+-ATPase accumulation in epididymal clear cells | Q24657352 | ||
AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function | Q26865723 | ||
Cellular and molecular mechanisms of metformin: an overview | Q27013561 | ||
Diversity of the mammalian sodium/proton exchanger SLC9 gene family | Q28185218 | ||
Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells | Q28214600 | ||
Design of glycolysis | Q28260372 | ||
The LKB1 tumor suppressor negatively regulates mTOR signaling | Q28272728 | ||
Adenosine 5'-triphosphate-sensitive potassium channels | Q28307662 | ||
Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes | Q28507590 | ||
Glucose deprivation regulates KATP channel trafficking via AMP-activated protein kinase in pancreatic beta-cells | Q28566857 | ||
Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase | Q28567006 | ||
KCNQ1-dependent transport in renal and gastrointestinal epithelia | Q28576069 | ||
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade | Q28610414 | ||
Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology | Q29614686 | ||
Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro | Q33249851 | ||
Kinetic evidence for unique regulation of GLUT4 trafficking by insulin and AMP-activated protein kinase activators in L6 myotubes | Q33581841 | ||
Vacuolar H+-ATPase apical accumulation in kidney intercalated cells is regulated by PKA and AMP-activated protein kinase | Q33840526 | ||
Role of the energy sensor AMP-activated protein kinase in renal physiology and disease | Q33840570 | ||
Regulation of the creatine transporter by AMP-activated protein kinase in kidney epithelial cells | Q33995147 | ||
The kidney as a target of hypertension. | Q34028197 | ||
PKA regulates vacuolar H+-ATPase localization and activity via direct phosphorylation of the a subunit in kidney cells | Q34042653 | ||
Quantitative phosphoproteomic analysis reveals cAMP/vasopressin-dependent signaling pathways in native renal thick ascending limb cells | Q34100251 | ||
SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy | Q34101200 | ||
The outcome of renal ischemia-reperfusion injury is unchanged in AMPK-β1 deficient mice | Q34130765 | ||
Renal vacuolar H+-ATPase | Q34350645 | ||
AS160 Associates with the Na+,K+-ATPase and Mediates the Adenosine Monophosphate-stimulated Protein Kinase-dependent Regulation of Sodium Pump Surface Expression | Q34408505 | ||
AMP-activated protein kinase inhibits KCNQ1 channels through regulation of the ubiquitin ligase Nedd4-2 in renal epithelial cells | Q34426341 | ||
Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. | Q34438345 | ||
Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis | Q34573001 | ||
Hypoxia Leads to Na,K-ATPase Downregulation via Ca2+ Release-Activated Ca2+ Channels and AMPK Activation | Q35192115 | ||
Preactivation of AMPK by metformin may ameliorate the epithelial cell damage caused by renal ischemia | Q35601616 | ||
AMP-activated protein kinase connects cellular energy metabolism to KATP channel function | Q35641881 | ||
A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway | Q35768634 | ||
The AMP-activated protein kinase pathway--new players upstream and downstream. | Q35930365 | ||
Emerging role of AMP-activated protein kinase in coupling membrane transport to cellular metabolism | Q36208686 | ||
AMP-activated protein kinase and the regulation of glucose transport | Q36528251 | ||
Molecular mechanisms and regulation of furosemide-sensitive Na-K-Cl cotransporters. | Q36568214 | ||
AMP-activated protein kinase in the heart: role during health and disease | Q36749088 | ||
Alpha1-AMP-activated protein kinase regulates hypoxia-induced Na,K-ATPase endocytosis via direct phosphorylation of protein kinase C zeta | Q37233450 | ||
Mechanisms of ENaC regulation and clinical implications | Q37254732 | ||
AMP-activated protein kinase phosphorylation of the R domain inhibits PKA stimulation of CFTR. | Q37264143 | ||
Resistin-like molecule-beta inhibits SGLT-1 activity and enhances GLUT2-dependent jejunal glucose transport. | Q37317481 | ||
AMPK in Health and Disease | Q37543855 | ||
Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target. | Q37790424 | ||
Energy sensing by the AMP-activated protein kinase and its effects on muscle metabolism. | Q37808513 | ||
Glucose handling by the kidney | Q37848041 | ||
PPAR-γ and AMPK – Advantageous targets for myocardial ischemia/reperfusion therapy | Q37871121 | ||
Sodium-dependent glucose transporter protein as a potential therapeutic target for improving glycemic control in diabetes | Q37963544 | ||
Dapagliflozin: A Novel Sodium‐Glucose Cotransporter Type 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus | Q37990891 | ||
Upregulation of Na+/H+ exchanger by the AMP-activated protein kinase | Q39683357 | ||
Renal energy metabolism and sodium reabsorption | Q39886843 | ||
Low salt concentrations activate AMP-activated protein kinase in mouse macula densa cells | Q39889854 | ||
AICAR activates AMPK and alters PIP2 association with the epithelial sodium channel ENaC to inhibit Na+ transport in H441 lung epithelial cells | Q39955492 | ||
Pharmacological activators of AMP-activated protein kinase have different effects on Na+ transport processes across human lung epithelial cells | Q40113099 | ||
Regulation of the renal-specific Na+-K+-2Cl- co-transporter NKCC2 by AMP-activated protein kinase (AMPK). | Q40162784 | ||
AMP-activated kinase inhibits the epithelial Na+ channel through functional regulation of the ubiquitin ligase Nedd4-2. | Q40255214 | ||
Phenformin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) activation of AMP-activated protein kinase inhibits transepithelial Na+ transport across H441 lung cells. | Q40416595 | ||
Epithelial sodium channel inhibition by AMP-activated protein kinase in oocytes and polarized renal epithelial cells. | Q40449460 | ||
Regulation of the energy sensor AMP-activated protein kinase in the kidney by dietary salt intake and osmolality | Q40493855 | ||
The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors | Q40501748 | ||
AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells | Q41419182 | ||
CFTR is required for PKA-regulated ATP sensitivity of Kir1.1 potassium channels in mouse kidney | Q42018121 | ||
Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells | Q42132375 | ||
Rapid activation of GLUT1 by osmotic stress | Q42797938 | ||
5-aminoimidazole-4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AMPK. | Q42813833 | ||
Metformin-induced regulation of the intestinal D-glucose transporters. | Q42976856 | ||
In vivo stimulation of AMP-activated protein kinase enhanced tubuloglomerular feedback but reduced tubular sodium transport during high dietary NaCl intake | Q43116158 | ||
Regulation of Na+-coupled glucose carrier SGLT1 by AMP-activated protein kinase | Q43119906 | ||
Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection | Q44763894 | ||
Electrical remodeling in a canine model of ischemic cardiomyopathy | Q44922674 | ||
Attenuation of ischemia-reperfusion injury in a canine model of autologous renal transplantation | Q45061944 | ||
Insulin and contraction stimulate exocytosis, but increased AMP-activated protein kinase activity resulting from oxidative metabolism stress slows endocytosis of GLUT4 in cardiomyocytes | Q45158699 | ||
Cardiac glycogen accumulation after dexamethasone is regulated by AMPK. | Q46403678 | ||
Regulation of Cl(-) secretion by AMPK in vivo | Q46408447 | ||
Acute renal ischemia rapidly activates the energy sensor AMPK but does not increase phosphorylation of eNOS-Ser1177. | Q46508470 | ||
KCa3.1 potassium channels are critical for cAMP-dependent chloride secretion and cyst growth in autosomal-dominant polycystic kidney disease | Q46544739 | ||
Oxidative stress induces GLUT4 translocation by activation of PI3-K/Akt and dual AMPK kinase in cardiac myocytes | Q46830178 | ||
Inhibition of the heterotetrameric K+ channel KCNQ1/KCNE1 by the AMP-activated protein kinase | Q48683488 | ||
AMPK controls epithelial Na(+) channels through Nedd4-2 and causes an epithelial phenotype when mutated | Q51743550 | ||
Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. | Q52182292 | ||
AMPK is a direct adenylate charge-regulated protein kinase. | Q54580866 | ||
Avian renal proximal tubule urate secretion is inhibited by cellular stress-induced AMP-activated protein kinase | Q54601736 | ||
A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy | Q64018940 | ||
The ATP dependence of a ouabain-sensitive sodium efflux activated by external sodium potassium and lithium in human red cells | Q67460784 | ||
Cystic fibrosis | Q70796417 | ||
Differential expression of KvLQT1 and its regulator IsK in mouse epithelia | Q73512897 | ||
Active cation transport as a pace-maker of respiration | Q79106339 | ||
Effect of N-acetylcysteine on plasma adiponectin and renal adiponectin receptors in streptozotocin-induced diabetic rats | Q79706734 | ||
Cellular distribution of the potassium channel KCNQ1 in normal mouse kidney | Q80077989 | ||
Role of angiotensin II-mediated AMPK inactivation on obesity-related salt-sensitive hypertension | Q83368572 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 523-533 | |
P577 | publication date | 2012-09-01 | |
P1433 | published in | Current Opinion in Nephrology and Hypertension | Q15756282 |
P1476 | title | AMP-activated protein kinase regulation of kidney tubular transport | |
P478 | volume | 21 |
Q58607160 | AMP-Activated Protein Kinase (AMPK)-Dependent Regulation of Renal Transport |
Q57844806 | AMP-Activated Protein Kinase as a Reprogramming Strategy for Hypertension and Kidney Disease of Developmental Origin |
Q37234794 | AMP-activated protein kinase regulates the vacuolar H+-ATPase via direct phosphorylation of the A subunit (ATP6V1A) in the kidney |
Q90363813 | AMPK phosphorylation of the β1Pix exchange factor regulates the assembly and function of an ENaC inhibitory complex in kidney epithelial cells |
Q64276303 | AMPK-Mediated Regulation of Alpha-Arrestins and Protein Trafficking |
Q39007844 | Activation of AMPK reduces the co-transporter activity of NKCC1. |
Q38734414 | Activation of the metabolic sensor AMP-activated protein kinase inhibits aquaporin-2 function in kidney principal cells |
Q35137688 | Adenosine monophosphate-activated protein kinase activation protects against sepsis-induced organ injury and inflammation |
Q51353323 | Cross-talk between AMP-activated protein kinase and renin-angiotensin system in uninephrectomised rats |
Q54420876 | Energy policy of the kidney: launch of AMPK as a novel therapeutic target |
Q37142481 | Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease |
Q51145526 | Kidney-specific genetic deletion of both AMPK α-subunits causes salt and water wasting. |
Q53728618 | Metformin + Sodium-glucose Co-transporter-2 Inhibitor: Salutogenic Lifestyle Mimetics in a Tablet? |
Q46948710 | Metformin induces renal medullary interstitial cell apoptosis in type 2 diabetic mice |
Q36957103 | Metformin, an AMPK activator, stimulates the phosphorylation of aquaporin 2 and urea transporter A1 in inner medullary collecting ducts. |
Q35749664 | Muc1 is protective during kidney ischemia-reperfusion injury |
Q37139453 | New insights into the molecular regulation of urine concentration |
Q39026988 | Pharmacological AMP kinase activators target the nucleolar organization and control cell proliferation. |
Q30421628 | Regulation of ion channels and transporters by AMP-activated kinase (AMPK). |
Q33568911 | Regulation of proximal tubule vacuolar H(+)-ATPase by PKA and AMP-activated protein kinase |
Q55026930 | Rethinking the regulation of l-carnitine transport in skeletal muscle cells. Focus on "Multiple AMPK activators inhibit l-carnitine uptake in C2C12 skeletal muscle myotubes". |
Q36286123 | Role of Binding and Nucleoside Diphosphate Kinase A in the Regulation of the Cystic Fibrosis Transmembrane Conductance Regulator by AMP-activated Protein Kinase |
Q93067493 | Role of PKC and AMPK in hypertonicity-stimulated water reabsorption in rat inner medullary collecting ducts |
Q35027212 | Stanniocalcin-1 inhibits renal ischemia/reperfusion injury via an AMP-activated protein kinase-dependent pathway |
Q54977349 | β1Pix exchange factor stabilizes the ubiquitin ligase Nedd4-2 and plays a critical role in ENaC regulation by AMPK in kidney epithelial cells. |
Search more.